Optomechanical sideband cooling of a thin membrane within a cavity von Karuza, M, Molinelli, C, Galassi, M, Biancofiore, C, Natali, R, Tombesi, P, Di Giuseppe, G, Vitali, D

Volltext

Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond von Sirico, M., Jacobs, F., Molinelli, C., Nader-Marta, Guilherme, Debien, V., Dewhurst, H. Faith, Palleschi, M., Merloni, F., Gianni, C., De Giorgi, U., de Azambuja, Evandro

Volltext

Tunable linear and quadratic optomechanical coupling for a tilted membrane within an optical cavity: theory and experiment von Karuza, M, Galassi, M, Biancofiore, C, Molinelli, C, Natali, R, Tombesi, P, Di Giuseppe, G, Vitali, D

Volltext

Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis von Molinelli, C., Jacobs, F., Agostinetto, E., Nader-Marta, G., Ceppi, M., Bruzzone, M., Blondeaux, E., Schettini, F., Prat, A., Viale, G., Del Mastro, L., Lambertini, M., de Azambuja, E.

Volltext

Optomechanically induced transparency in a membrane-in-the-middle setup at room temperature von Karuza, M., Biancofiore, C., Bawaj, M., Molinelli, C., Galassi, M., Natali, R., Tombesi, P., Di Giuseppe, G., Vitali, D.

Volltext

Effectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab von Conte, B., Fabi, A., Poggio, F., Blondeaux, E., Dellepiane, C., D'Alonzo, A., Staiano, A., Buono, G., Arpino, G., Magri, V., Naso, G., Presti, D., Mura, S., Fontana, A., Cognetti, F., Molinelli, C., Pastorino, S., Bighin, C., Lambertini, M., Del Mastro, L.

Volltext

Hydronephrosis and crossing vessels in children: Optimization of diagnostic-therapeutic pathway and analysis of color Doppler ultrasound and magnetic resonance urography diagnostic... von Wong, M.C.Y., Piaggio, G., Damasio, M.B., Molinelli, C., Ferretti, S.M., Pistorio, A., Ghiggeri, G., Degl'Innocenti, M.L., Canepa, A., Incarbone, V., Mattioli, G.

Volltext

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial von Poggio, F., Blondeaux, E., Tagliamento, M., Perachino, M., Nardin, S., Conte, B., Giuliano, M., Arpino, G., De Laurentiis, M., Gravina, A., Bisagni, G., Rimanti, A., Turletti, A., Nisticò, C., Magnolfi, E., Gasparro, S., Fabi, A., Garrone, O., Alicicco, M.G., Urracci, Y., Poletti, P., Correale, P., Molinelli, C., Fozza, A., Puglisi, F., Colantuoni, G., Fregatti, P., Boni, L., Lambertini, M., Del Mastro, L.

Volltext

Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404] von Sirico, M., Jacobs, F., Molinelli, C., Nader-Marta, Guilherme, Debien, V., Dewhurst, H.Faith, Pallesch, M., Merloni, F., Gianni, C., De Giorgi, U., de Azambuja, Evandro

Volltext

459P Progression-free survival (PFS) assessment by local investigators versus blinded independent central review (BICR) in randomized clinical trials (RCTs) in metastatic breast ca... von Jacobs, F., Molinelli, C., Agostinetto, E., Branco, D. Martins, Marta, G. Nader, Salmon, M., Ameye, L., Piccart, M., Lambertini, M., de Azambuja, E.

Volltext

290P Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: A nationwide population-based study von Marta, G. Nader, Ameye, L., Branco, D. Martins, Salgado, R.F., Van Damme, N., Verbeeck, J., Aftimos, P.G., Buisseret, L., Paesmans, M., Molinelli, C., Lambertini, M., Van Baelen, K., Desmedt, C., Piccart, M., de Azambuja, E.

Volltext

Observation of three-mode parametric instability von Chen, X., Zhao, C., Danilishin, S., Ju, L., Blair, D., Wang, H., Vyatchanin, S. P., Molinelli, C., Kuhn, A., Gras, S., Briant, T., Cohadon, P.-F., Heidmann, A., Roch-Jeune, I., Flaminio, R., Michel, C., Pinard, L.

Volltext

Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study von Schettini, Francesco, Blondeaux, Eva, Molinelli, Chiara, Bas, Raphaëlle, Kim, Hee Jeong, Di Meglio, Antonio, Bernstein Molho, Rinat, Linn, Sabine C., Pogoda, Katarzyna, Carrasco, Estela, Punie, Kevin, Agostinetto, Elisa, Lopetegui‐Lia, Nerea, Phillips, Kelly‐Anne, Toss, Angela, Rousset‐Jablonski, Christine, Acheritogaray, Marion, Ferrari, Alberta, Paluch‐Shimon, Shani, Fruscio, Robert, Cui, Wanda, Wong, Stephanie M., Vernieri, Claudio, Dieci, Maria Vittoria, Matikas, Alexios, Rozenblit, Mariya, Villarreal‐Garza, Cynthia, De Marchis, Laura, Puglisi, Fabio, Vasconcelos de Matos, Leonor, Mariño, Monica, Teixeira, Luis, Graffeo, Rossella, Rognone, Alessia, Chirco, Alessandra, Antone, Nicoleta, Abdou, Yara, Marhold, Maximilian, Božović‐Spasojević, Ivana, Cortés Salgado, Alfonso, Carmisciano, Luca, Bruzzone, Marco, Curigliano, Giuseppe, Prat, Aleix, Lambertini, Matteo

Volltext

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study von Molinelli, C., Del Mastro, L., Giraudi, S., Ballestrero, A., Carli, F., Poggio, F., D'Alonzo, A., Dellepiane, C., Buzzatti, G., Blondeaux, E., Conte, B., Pastorino, S., Gallo, M., Lambertini, M., Bighin, C.

Volltext

337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study von Nichetti, F., Marra, A., Giorgi, C.A., Randon, G., Scagnoli, S., De Angelis, C., Molinelli, C., Ferraro, E., Trapani, D., Milani, A., Agostinetto, E., Bernocchi, O., Catania, G., Rea, C.G., Basile, D., Gerratana, L., Cinausero, M., Vernieri, C.

Volltext

Corrigendum to "Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond" Crit. Rev. Oncol./Hematol. 200C (2024) 104404 von Sirico, M, Jacobs, F, Molinelli, C, Nader-Marta, Guilherme, Debien, V, Dewhurst, H Faith, Pallesch, M, Merloni, F, Gianni, C, De Giorgi, U, de Azambuja, Evandro

Volltext

307P Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer von Blondeaux, E., Boni, L., Ruelle, T., Di Lauro, V., Molinelli, C., Piezzo, M., Fratini, B., Poggio, F., Pugliese, P., Ferzi, A., Buzzatti, G., Russo, S., Garrone, O., Gasparro, S., D'Alonzo, A., De Laurentiis, M., Fabi, A., Arpino, G., Bighin, C., Del Mastro, L.

Volltext

64P Baseline characteristics associated with Ki67 drop after neoadjuvant endocrine therapy in patients with HR+/HER2- early breast cancer: A systematic review von Branco, D. Martins, Molinelli, C., Marta, G. Nader, Ameye, L., Paesmans, M., Salgado, R.F., Aftimos, P.G., de Azambuja, E.

Volltext

326PEffectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab von Conte, B, Fabi, A, Poggio, F, Blondeaux, E, Dellepiane, C, D'Alonzo, A, Staiano, A, Buono, G, Arpino, G, Magri, V, Naso, G, Presti, D, Mura, S, Fontana, A, Cognetti, F, Molinelli, C, Pastorino, S, Bighin, C, Lambertini, M, Del Mastro, L

Volltext

290P Adverse events (AEs) and impact on quality of life (QoL) of antibody-drug conjugates (ADC) in the treatment of metastatic breast cancer (mBC): A systematic review and meta-ana... von Perachino, M., Blondeaux, E., Molinelli, C., Ruelle, T., Giannubilo, I., Arecco, L., Nardin, S., Razeti, M.G., Borea, R., Favero, D., Lanzavecchia, C., Chiappe, E., Tomasello, L.M., Mariamidze, E., Jankovic, K., Zahari, M.M., Scavone, G., Ottonello, S., Manich, C. Saura, Lambertini, M.

Volltext